Precision Oncology: a Clinical and Patient Perspective
Open Access
- 19 July 2021
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 17 (30) , 3995-4009
Abstract
Molecular characterization of tumors has shifted cancer treatment strategies away from nonspecific cytotoxic treatment of histology-specific tumors toward targeting of actionable mutations that can... Lay abstract Precision oncology offers individualized treatment of cancer on a per-patient basis, based on the unique DNA fingerprint of a patient’s cancer. New, advanced technologies for DNA seque...Keywords
Funding Information
- Bayer
This publication has 69 references indexed in Scilit:
- Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment ResponseJAMA Oncology, 2015
- Barriers Prevent Patient Access to Personalized Therapies Identified by Molecular Tumor Profiling of Gynecologic MalignanciesJournal of Personalized Medicine, 2015
- EGFR: The Paradigm of an Oncogene-Driven Lung CancerClinical Cancer Research, 2015
- A Decision Support Framework for Genomically Informed Investigational Cancer TherapyJNCI: Journal of the National Cancer Institute, 2015
- Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemiaJournal of Clinical Investigation, 2015
- Molecular Tumor Board: The University of California San Diego Moores Cancer Center ExperienceThe Oncologist, 2014
- Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating AgentsClinical Cancer Research, 2013
- Physical Activity in Patients With Advanced-Stage Cancer: A Systematic Review of the LiteratureClinical Journal of Oncology Nursing, 2012
- The role of BRAF V600 mutation in melanomaJournal of Translational Medicine, 2012
- Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal CancerCancer Research, 2012